Watch: VisionSort Morphometry
VisionSort Morphometry
Our latest morphometry data! Presented by ThinkCyte’s Head of Research, Dr. Romain Ballet, this ~30 minute seminar takes a deep dive into how high resolution cellular morphotyping unveils insights into complex phenotypes that markers miss. From cellular differentiation to antibody internalization, this seminar showcases real world data from ThinkCyte Discovery Labs with applications in drug discovery, regenerative medicine, and translational medicine.
Watch: 2024 Advances in Cell Sorting Symposium
2024 Advances in Cell Sorting Symposium
Watch: VisionSort in Imaging and AI Webinar
VisionSort in Imaging and AI Webinar
VisionSort for Drug Discovery
Watch: VisionSort for Drug Discovery
VisionSort: A New Dimension in Cell Analysis & Sorting
Watch: VisionSort: A New Dimension in Cell Analysis & Sorting (JPN/日本語)
VisionSort: A New Dimension in Cell Analysis & Sorting (JPN/日本語)
Watch: VisionSort: A New Dimension in Cell Analysis & Sorting
VisionSort for Cell Therapy R&D: T-Cells (JPN/日本語)
Watch: VisionSort for Cell Therapy (T-Cell) (JPN/日本語)
VisionSort for Cell Therapy R&D (JPN/日本語)
Watch: VisionSort for Cell Therapy R&D (JPN/日本語)
Watch: VisionSort: Applications in Stem Cell R&D Webinar
VisionSort: Applications in Stem Cell R&D Webinar
Learn more about VisionSort applications in stem cell R&D and regenerative medicine. Highlights include applications in induced pluripotent stem cells (iPSC), human mesenchymal stem cells (hMSC), and progenitor cells. Combining gentle microfluidics based sorting that maintains stem cell viability and differentiation potential with sensitive, label-free isolation of specific cell phenotypes, VisionSort is uniquely positioned to address fundamental challenges in stem cell R&D and regenerative medicine.
VisionSort for Phenotypic Drug Screening (JPN/日本語)
VisionSort for Phenotypic Drug Screening
Learn more about VisionSort applications in phenotypic drug screening. Providing a perfect complement to existing drug discovery technologies, see how the power of AI and high-resolution morphological profiling come together to enable new phenotypes to screen for and the identification of differentiated hits for discovery campaigns.
